Cementless Total Knee Arthroplasty Market Research, 2032
The global cementless total knee arthroplasty market size was valued at $1.9 billion in 2022, and is projected to reach $3 billion by 2032, growing at a CAGR of 4.6% from 2023 to 2032. Cementless fixation is a reliable, durable fixation option for patients undergoing primary total knee arthroplasty (TKA) and is especially attractive for younger and more active patients. Advances in fixation materials such as modern highly porous metals provide an additional adjunct in promoting osseointegration and longer-term success. Cementless prostheses remain an intriguing option because of the potential for biologic fixation and improved survivorship.
Implants can also be press-fit onto bone. This type of fixation relies on new bone growth onto the surface of the implant. Cementless implants are made of a material that attracts new bone growth. Most are textured or coated so that the new bone actually grows onto the surface of the implant.
Market dynamics
The key drivers of the cementless total knee arthroplasty industry growth are the rise in the prevalence of knee osteoarthritis and advancements in implant design, materials, and surgical methods. For instance, the Global RA Network study from 2021 claims that more than 350 million people worldwide have arthritis, with up to 3% of the population suffering from psoriatic arthritis and 14 million with rheumatoid arthritis.
In addition, as sports-related injuries become more common, more people will suffer from muscle and tendon diseases, which will increase the need for cementless knee implants and fuel the cementless total knee arthroplasty market growth. Another significant element driving the expansion of the market is the rise in the number of elderly people who are suffering from osteoarthritis.
Furthermore, an increase in prevalence of obesity as the obese population is at a higher risk of arthritis and advantages of cementless knee replacement over traditional cemented implants propel the growth of the market. As, cementless implants provide better fixation and stability, reduced risk of loosening over time, and improved long-term survival rates. These benefits have led to an increased adoption of cementless total knee arthroplasty (TKA) by surgeons and patients.
Segmental Overview
The global cementless total knee arthroplasty market share is segmented into product, material, end user, and region. On the basis of the product, the market is segmented into mobile bearings and fixed bearings. On the basis of the material, the market is segmented into ceramics, alloys and others. Depending on the end user, the cementless total knee arthroplasty market is segmented into hospitals and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
By Product
The cementless total knee arthroplasty market share is segmented into mobile bearings and fixed bearings. The fixed bearings segment generated maximum revenue in 2022, owing to various benefits offered by fixed-bearing platform such as it used as a standard for many cementless total knee arthroplasty (TKA) implants because of its simple design and low cost compared with mobile-bearing/rotating-platform implants. The same segment is expected to witness the highest CAGR during the forecast period.
By Material
The cementless total knee arthroplasty market is segregated into ceramic, alloys and other. The alloy segment dominated the market in 2022, owing to the various benefits offered by alloys such as biocompatibility with human tissue, improved implant fixation and excellent wear resistance. The same segment is expected to witness the highest CAGR during the forecast period.
By End User
The cementless total knee arthroplasty market is segregated into hospitals and others. The hospitals segment dominated the market in 2022, owing to increase in the number of knee arthroplasty procedures conducted globally and availability of specialized orthopedic surgeons in hospitals. The others segment is expected to witness the highest CAGR during the forecast period owing to an increase in the patient preference for outpatients' surgeries at ambulatory surgical centers and orthopedic clinics.
By Region
The cementless total knee arthroplasty market size is studied across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major share of the cementless total knee arthroplasty market in 2022 and is expected to maintain its dominance during the forecast period. This is attributed to publicly funded healthcare systems, where the government Medicare covers the majority of the cost of medical treatment, surgeries, and orthopedic implants. In addition, the total number of patients undergoing total knee arthroplasty is relatively high in the developed countries such as the U.S. and Canada, as compared to other countries in the region.
Asia-Pacific is expected to witness growth at the highest rate during the cementless total knee arthroplasty market forecast. Owing to highly populated countries along with a high prevalence of road accidents and osteoarthritis. In addition, the increasing number of sports tournaments conducted annually increases the rate of sports-related injuries, thereby increasing the demand for cementless knee arthroplasty implants, which provide lucrative opportunities for market growth.
Competition Analysis
Competitive analysis and profiles of the major players in the cementless total knee arthroplasty industry such as Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Stryker Corporation, Johnson & Johnson, B. Braun Melsungen AG, Microport Scientific Corporation, Olympus Corporation (Group FH Ortho), Waldemar Link GmbH & Co. KG, United Orthopedic Corporation, and X. NOV.
The key players such as Zimmer Biomet Holdings Inc., Smith & Nephew PLC and Johnson & Johnson have adopted product launch and innovation as major developmental strategies to improve their product portfolio.
Recent Product Launch in the Cementless Total Knee Arthroplasty Market
In November 2022, Zimmer Biomet Holdings, Inc. announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for the Persona OsseoTi Keel Tibia for cementless knee replacement.
In November 2022, Smith & Nephew announced the introduction of its JOURNEY II ROX Total Knee Solution – a reverse hybrid construct for total knee arthroplasty. This new procedural product solution aims to provide surgeons with the clinical advantage of an advanced bearing material and anatomic design combined with the efficiency and potential long-term tibia fixation of a cementless knee.
In September 2019, Johnson & Johnson launched DePuy Synthes ATTUNE Cementless Knee in a rotating platform option around the world. This launch combines the proprietary technologies of the ATTUNE Knee designed to provide stability while the knee is in motion with DePuy Synthes’ extensive heritage in rotating platform knees and cementless technology.
Recent Innovation in the Cementless Total Knee Arthroplasty Market
In March 2022, Johnson & Johnson MedTech announced DePuy Synthes has added two new innovations to its kinematically advanced ATTUNE Knee portfolio the ATTUNE Cementless Fixed Bearing Knee with AFFIXIUM 3DP Technology and the ATTUNE Medial Stabilized Knee System.
Key benefits for stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cementless total knee arthroplasty market analysis from 2022 to 2032 to identify the prevailing cementless total knee arthroplasty market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cementless total knee arthroplasty market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global cementless total knee arthroplasty market trends, key players, market segments, application areas, and market growth strategies.
Cementless total knee arthroplasty Market Report Highlights
| Aspects | Details |
 Market Size By 2032 | USD 3 billion |
 Growth Rate | CAGR of 4.6% |
 Forecast period | 2022 - 2032 |
 Report Pages | 372 |
 By Product |
|
 By Material |
|
 By End User |
|
 By Region |
|
 Key Market Players | United Orthopedic Corporation, B. Braun Melsungen AG, X. NOV, Zimmer Biomet Holding Inc., Johnson & Johnson, Waldemar Link GmbH & Co. KG, Stryker Corporation., Smith & Nephew plc, MicroPort Scientific Corporation, Olympus Corporation |
Analyst Review
This section provides the opinions of top level CXOs in the cementless total knee arthroplasty market. According to several interviews conducted, cementless total knee arthroplasty has gained high traction due to increase in prevalence of osteoarthritis and rheumatoid arthritis and growth in aging population. The CXOs further added that significant technological advancements for the development of innovative implant designs and surgical techniques in cementless knee arthroplasty, increasing demand for 3D-printed knee implants and the rise in the number of sports injuries are the major factors that drive the growth of the market.
Moreover, the demand for cementless total knee arthroplasty services is on the rise as people are becoming more conscious about maintaining an active and healthy lifestyle, even as they age and various advantages of cementless knee arthroplasty over the traditional cemented approach are the factors that boost the market growth. Furthermore, the surge in investments in R&D by pharmaceutical companies, the growth in healthcare expenditure, and the increase in adoption of cementless knee arthroplasty implants owing to medical cases, old age, or any temporary disability are the key factors driving the growth of the market.
However, the limited awareness in developing countries and rural areas, and high cost of cementless knee implant devices are the factors that restrain the growth of the market. Conversely, rapid growth was observed in the prevalence of knee injury, and rise in medical tourism, where patients travel abroad for affordable and high-quality healthcare, is expected to provide lucrative opportunities for the growth of the cementless knee arthroplasty market.
North America has the highest market share in 2022 and is expected to maintain its lead during the forecast period, in terms of revenue, owing to presence of large number of key market players and easy availability of technologically advanced medical devices used in total knee arthroplasty in developed countries such as the U.S. and Canada. In addition, emerging economies such as India, China, Mexico, and Brazil, are expected to offer lucrative opportunities owing to the lack of medical facilities and awareness in these countries, increase in prevalence of chronic ailments such as osteoarthritis and rapidly growing geriatric population.
Cementless implants have shown to reduce the prevalence of radiological radiolucent lines (RLL), which may help to improve implant survivorship and reduce revision rates compared to cemented implants for uni-compartmental knee arthroplasty (UKA) and total knee arthroplasty (TKA).
The total market value of the cementless total knee arthroplasty is $1938.81 million in 2022.
The forecast period for cementless total knee arthroplasty market is 2023 to 2032
The base year is 2022 in cementless total knee arthroplasty market.
Rise in prevalence of knee osteoarthritis, Technological advancements in knee arthroplasty implants and rise in the number of sports related injuries.
Top companies such as Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Stryker Corporation, Johnson & Johnson, B. Braun Melsungen AG, Microport Scientific Corporation, Olympus Corporation (Group FH Ortho), Waldemar Link GmbH & Co. KG, United Orthopedic Corporation, and X. NOV held a high market position in 2022.
Yes, the competitive landscape is included in the cementless total knee arthroplasty report.
Fixed bearings segment dominated the global market in 2022 and expected to continue this trend throughout the forecast period.
Loading Table Of Content...
Loading Research Methodology...
